Skip to content
FDA.report
Public FDA data
NDC
RxNorm
DailyMed
Applications
GUDID
PMA
PMN
MAUDE
Recalls
Search FDA.report
Search
Home
DailyMed
product-concept
470fcae6-c316-0386-e573-8b9b4af2f6cd
TAFLUPROST - Food and Drug Administration
Set ID
470fcae6-c316-0386-e573-8b9b4af2f6cd
Type
Indexing - Product Concept
Effective date
2025-01-29
Version
4
Source
DailyMed source
Mapped DailyMed Labels
#
Label, Relation, Manufacturer table
Label
Relation
Manufacturer
Effective
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Product name
Sandoz Inc
2026-08-15
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Product name
Thea Pharma Inc.
2026-04-23
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Product name
Sandoz Inc
2026-03-25
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Product name
Micro Labs Limited
2026-03-06
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Product name
Thea Pharma Inc.
2026-03-02
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 2012
Product name
Ingenus Pharmaceuticals, LLC | Kaysersberg Pharmaceuticals
2024-12-04
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Product name
Akorn
2022-10-04
These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 2012
Product name
Prasco Laboratories
2022-06-01
Related NDC Packages
#
NDC, DailyMed label, Manufacturer table
NDC
DailyMed label
Manufacturer
0781-6184
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Sandoz Inc
0781-6184-14
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Sandoz Inc
0781-6184-87
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Sandoz Inc
17478-609
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Akorn
17478-609-01
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Akorn
17478-609-10
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Akorn
17478-609-30
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Akorn
17478-609-90
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Akorn
42571-264
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Micro Labs Limited
42571-264-26
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Micro Labs Limited
42571-264-73
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Micro Labs Limited
42571-264-74
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Micro Labs Limited
50742-339
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 2012
Ingenus Pharmaceuticals, LLC | Kaysersberg Pharmaceuticals
50742-339-05
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 2012
Ingenus Pharmaceuticals, LLC | Kaysersberg Pharmaceuticals
50742-339-30
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 2012
Ingenus Pharmaceuticals, LLC | Kaysersberg Pharmaceuticals
66993-429
These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 2012
Prasco Laboratories
66993-429-30
These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 2012
Prasco Laboratories
66993-429-81
These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 2012
Prasco Laboratories
82584-609
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Thea Pharma Inc.
82584-609-01
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Thea Pharma Inc.
82584-609-30
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Thea Pharma Inc.